Company Profiles

driven by the PitchBook Platform

AmVac

Description

Developer of vaccines designed to offer breakthrough results from basic research efficiently into the industrial development. The company's vaccines are innovative and safe that enhance human health and improve scientific understanding of immunological conditions and focuses on the fast growing vaccine market in the fields of gynecology, urology and lung diseases, enabling patients to have stimulated immune system against invading pathogens.

2005

Founded

OOB

Status

11-50

Employees

Liquidation

Latest Deal Type

$4M

Total Amount Raised

Description

Developer of vaccines designed to offer breakthrough results from basic research efficiently into the industrial development. The company's vaccines are innovative and safe that enhance human health and improve scientific understanding of immunological conditions and focuses on the fast growing vaccine market in the fields of gynecology, urology and lung diseases, enabling patients to have stimulated immune system against invading pathogens.

Website:

www.amvac.eu

Ownership Status

Out of Business

Financing Status

Formerly VC-Backed

Primary Industry

Drug Discovery

Primary Office

Baarerstrasse 22 6300 ZugSwitzerland +41 (0)41 725 3230
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore AmVac's full profile, request a free trial.

AmVac Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

AmVac Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Ali PashazadehChief Executive Officer
Marian Wiegand MDHead, Research & Development
Ali Pashazadeh Chief Executive Officer
Marian Wiegand MD Head, Research & Development

AmVac Board Members (2)

NameRepresentingRoleSinceContact
Info
Keith LuxonSelfPresident, Supervisory Board000 0000
Viktor SauterSelfBoard Member000 0000
Keith Luxon President, Supervisory Board Self
Viktor Sauter Board Member Self
Request full access to PitchBook